Gastric Emptying of High Calorie Liquid Meals
Ultrasound Assessment of Gastric Emptying After a Standardized High Calorie Liquid Meal in Adults: a Prospective Observational Double-blind Study
1 other identifier
interventional
25
1 country
1
Brief Summary
Perioperative fasting is an essential patient safety measure to reduce the risk of pulmonary aspiration of gastric contents, a rare but potentially catastrophic complication of anesthetic and airway management. Anesthesiologists' concern about aspiration and the increasing awareness towards the negative impact of prolonged restriction of oral intake have shaped the current fasting guidelines. However, due to the perceived safety of prolonged fasting and practical considerations, adoption of the fasting guidelines is suboptimal. Gastric ultrasound is a quick, non-invasive method to evaluate gastric contents and aspiration risk. Gastric ultrasound can accurately discriminate between solid particles and fluid content, and mathematical models can reliably predict the volume of the gastric contents from the gastric antral area (GAA). This project aims to use gastric ultrasound to provide new data that can support management strategies in perioperative patients, that ensure both a low aspiration risk and an adequate nutritional support. The investigators will test the hypothesis that commercially available liquid meals can be safely used preoperatively. A pilot crossover, study on healthy volunteers will be conducted to determine the gastric emptying time of high-calorie drinks, as compared to clear fluid.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 28, 2022
CompletedStudy Start
First participant enrolled
March 28, 2022
CompletedFirst Posted
Study publicly available on registry
April 18, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 18, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2022
CompletedAugust 12, 2022
August 1, 2022
2 months
March 28, 2022
August 11, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gastric emptying time
Time since ingestion of any of the study products until an empty stomach can be determined on ultrasound
Repeated ultrasound examinations will be performed every 30 minutes after the ingestion of the study product up to 6 hours after ingestion to determine whether the stomach has completely emptied.
Secondary Outcomes (1)
Gastric volume at prespecified intervals after ingestions
Ultrasound examinations will be repeated every 30 minutes after the ingestion of the study product up to 6 hours and the gastric antrum area and the gastric antrum cross-sectional area will be measured to estimate the volume of the gastric content.
Study Arms (6)
Sequence 123
EXPERIMENTALIn this study arm the following sequence of interventions will be administered: upon first study session, intervention #1 will be administered (Dietary Supplement: ProvideXtra Drink). upon second study session, intervention #2 will be administered (Dietary Supplement: Fresubin Energy Drink). upon third study session, intervention #3 will be administered (Dietary Supplement: Generic Glucose Solution).
Sequence 132
EXPERIMENTALIn this study arm the following sequence of interventions will be administered: upon first study session, intervention #1 will be administered (Dietary Supplement: ProvideXtra Drink). upon second study session, intervention #3 will be administered (Dietary Supplement: Generic Glucose Solution). upon third study session, intervention #2 will be administered (Dietary Supplement: Fresubin Energy Drink).
Sequence 213
EXPERIMENTALIn this study arm the following sequence of interventions will be administered: upon first study session, intervention #2 will be administered (Dietary Supplement: Fresubin Energy Drink). upon second study session, intervention #1 will be administered (Dietary Supplement: ProvideXtra Drink). upon third study session, intervention #3 will be administered (Dietary Supplement: Generic Glucose Solution).
Sequence 231
EXPERIMENTALIn this study arm the following sequence of interventions will be administered: upon first study session, intervention #2 will be administered (Dietary Supplement: Fresubin Energy Drink). upon second study session, intervention #3 will be administered (Dietary Supplement: Fresubin Energy Drink). upon third study session, intervention #1 will be administered (Dietary Supplement: ProvideXtra Drink).
Sequence 312
EXPERIMENTALIn this study arm the following sequence of interventions will be administered: upon first study session, intervention #3 will be administered (Dietary Supplement: Generic Glucose Solution). upon second study session, intervention #1 will be administered (Dietary Supplement: ProvideXtra Drink). upon third study session, intervention #2 will be administered (Dietary Supplement: Fresubin Energy Drink).
Sequence 321
EXPERIMENTALIn this study arm the following sequence of interventions will be administered: upon first study session, intervention #3 will be administered (Dietary Supplement: Generic Glucose Solution). upon second study session, intervention #2 will be administered (Dietary Supplement: Fresubin Energy Drink). upon third study session, intervention #1 will be administered (Dietary Supplement: ProvideXtra Drink).
Interventions
Fasted subjects will be offered 200 ml of ProvideXtra and will be asked to ingest it at a comfortable rate. Subsequent gastric ultrasound examinations will be performed half-hourly (up to 6 hours) to determine the volume of the gastric contents. The intervention ends when the stomach appears to be empty again on ultrasound.
Fasted subjects will be offered 200 ml of Fresubin Energy Drink and will be asked to ingest it at a comfortable rate. Subsequent gastric ultrasound examinations will be performed half-hourly to determine the volume of the gastric contents. The intervention ends when the stomach appears to be empty again on ultrasound.
Fasted subjects will be offered the glucose solution and will be asked to ingest it at a comfortable rate. Subsequent gastric ultrasound examinations will be performed half-hourly (up to 6 hours) to determine the volume of the gastric contents. The intervention ends when the stomach appears to be empty again on ultrasound.
Eligibility Criteria
You may qualify if:
- ASA 1 and 2
You may not qualify if:
- Allergy or intolerance to any of the study products or the ingredients
- Previous esophageal, gastric, or duodeno-pancreatic surgery
- Gastric banding or large hiatal hernia
- mmobility
- Contraindication to right lateral positioning
- Gastrointestinal diseases and disturbances
- Participation in another, possibly interfering study
- Diabetes mellitus
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University Vienna
Vienna, 1090, Austria
Related Publications (5)
Smith I, Kranke P, Murat I, Smith A, O'Sullivan G, Soreide E, Spies C, in't Veld B; European Society of Anaesthesiology. Perioperative fasting in adults and children: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2011 Aug;28(8):556-69. doi: 10.1097/EJA.0b013e3283495ba1.
PMID: 21712716BACKGROUNDTacken MCT, van Leest TAJ, van de Putte P, Keijzer C, Perlas A. Ultrasound assessment of gastric volumes of thick fluids: Validating a prediction model. Eur J Anaesthesiol. 2021 Dec 1;38(12):1223-1229. doi: 10.1097/EJA.0000000000001465.
PMID: 33606419BACKGROUNDPerlas A, Mitsakakis N, Liu L, Cino M, Haldipur N, Davis L, Cubillos J, Chan V. Validation of a mathematical model for ultrasound assessment of gastric volume by gastroscopic examination. Anesth Analg. 2013 Feb;116(2):357-63. doi: 10.1213/ANE.0b013e318274fc19. Epub 2013 Jan 9.
PMID: 23302981BACKGROUNDPerlas A, Arzola C, Van de Putte P. Point-of-care gastric ultrasound and aspiration risk assessment: a narrative review. Can J Anaesth. 2018 Apr;65(4):437-448. doi: 10.1007/s12630-017-1031-9. Epub 2017 Dec 11.
PMID: 29230709BACKGROUNDVan de Putte P, Perlas A. Ultrasound assessment of gastric content and volume. Br J Anaesth. 2014 Jul;113(1):12-22. doi: 10.1093/bja/aeu151. Epub 2014 Jun 3.
PMID: 24893784BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andreas Duma, MSc
Medical University of Vienna
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 28, 2022
First Posted
April 18, 2022
Study Start
March 28, 2022
Primary Completion
May 18, 2022
Study Completion
June 1, 2022
Last Updated
August 12, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- CSR, ANALYTIC CODE
- Time Frame
- Data will be available from the PI 10 years after study completion.
IPD will be accessed by the PI upon request.